SSY Groups (HKG:2005) attributable profit fell 20% to HK$1.06 billion in 2024 from HK$1.32 billion in 2023, according to a Friday filing with the Hong Kong bourse.

Earnings per share at the drug company decreased to HK$0.3581 from HK$0.4426 in the previous year.

Revenue declined 11% to HK$5.77 billion from HK$6.46 billion a year earlier.

The company declared a final dividend of HK$0.095 per share, payable June 3 to shareholders on record as of May 21.